Explore

Trendline Trendline
Compass Pathways to Engage in Jefferies Global Healthcare Conference

Compass Pathways to Engage in Jefferies Global Healthcare Conference

Compass Pathways to Engage in Jefferies Global Healthcare Conference
Trendline Trendline
Compass Pathways to Present at Jefferies Global Healthcare Conference

Compass Pathways to Present at Jefferies Global Healthcare Conference

Compass Pathways to Present at Jefferies Global Healthcare Conference
Trendline Trendline
Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval
Trendline Trendline
Veradermics to Present Phase 2/3 Study Results of VDPHL01 for Pattern Hair Loss at World Congress

Veradermics to Present Phase 2/3 Study Results of VDPHL01 for Pattern Hair Loss at World Congress

Veradermics to Present Phase 2/3 Study Results of VDPHL01 for Pattern Hair Loss at World Congress
Trendline Trendline
GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B

GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B

GSK's Bepirovirsen Shows Promising Cure Rates for Chronic Hepatitis B
Trendline Trendline
Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment
Trendline Trendline
Retension Pharmaceuticals Appoints New Executives to Advance Hypertension Treatment

Retension Pharmaceuticals Appoints New Executives to Advance Hypertension Treatment

Retension Pharmaceuticals Appoints New Executives to Advance Hypertension Treatment
Trendline Trendline
Verastem Oncology Appoints Michael P. Bailey to Board Amid Strategic Growth

Verastem Oncology Appoints Michael P. Bailey to Board Amid Strategic Growth

Verastem Oncology Appoints Michael P. Bailey to Board Amid Strategic Growth
Trendline Trendline
PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization for BESREMi Expansion

PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization for BESREMi Expansion

PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization for BESREMi Expansion
Trendline Trendline
Micron Biomedical Appoints New CFO to Advance Needle-Free Vaccine Technology

Micron Biomedical Appoints New CFO to Advance Needle-Free Vaccine Technology

Micron Biomedical Appoints New CFO to Advance Needle-Free Vaccine Technology
Trendline Trendline
Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer

Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer

Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer
Trendline Trendline
PharmaEssentia to Present New Data on Ropeginterferon Alfa-2b for Essential Thrombocythemia at ASCO and EHA 2026

PharmaEssentia to Present New Data on Ropeginterferon Alfa-2b for Essential Thrombocythemia at ASCO and EHA 2026

PharmaEssentia to Present New Data on Ropeginterferon Alfa-2b for Essential Thrombocythemia at ASCO and EHA 2026